BWAY
BrainsWay Ltd.
BWAY has the edge over UNH overall, supported by stronger fundamentals.
UNH
UnitedHealth Group Incorporated
UNH has lower modeled downside risk, despite its lower overall score.
BWAY Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Stable | |
| Healthy |
BWAY's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
BWAY PE Valuation
BWAY has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
BWAY Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
BWAY has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BWAY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.37 | +147% |
| Q1 2026 | $0.28 | +133% |
| Q4 2025 | $0.18 | +80% |
| Q3 2025 | $0.15 | +114% |
| Q2 2025 | $0.15 | +650% |
| Q1 2025 | $0.12 | +$0.17 |
| Q4 2024 | $0.10 | +$0.22 |
| Q3 2024 | $0.07 | +$0.32 |
BWAY has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
BWAY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $17.4M | +38% |
| Q1 2026 | $15.5M | +35% |
| Q4 2025 | $14.5M | +27% |
| Q3 2025 | $13.5M | +29% |
| Q2 2025 | $12.6M | +26% |
| Q1 2025 | $11.5M | +27% |
| Q4 2024 | $11.4M | +26% |
| Q3 2024 | $10.5M | +26% |
BWAY has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +9.4 points |
| Q1 2026 | 13% | +7.9 points |
| Q4 2025 | 13% | +9.4 points |
| Q3 2025 | 9.3% | +6.6 points |
| Q2 2025 | 4.6% | -1.3 points |
| Q1 2025 | 5% | +4 points |
| Q4 2024 | 3.8% | -108 points |
| Q3 2024 | 2.7% | +4.3 points |
BWAY has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
BWAY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $5.5M | -51% |
| Q1 2026 | $402K | -90% |
| Q4 2025 | -$759K | -130% |
| Q3 2025 | $586K | -40% |
| Q2 2025 | $11.2M | +2139% |
| Q1 2025 | $4M | +62% |
| Q4 2024 | $2.6M | +27% |
| Q3 2024 | $978K | +16% |
BWAY still generates free cash flow, though less than at its 2025 peak: $6M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over BWAY on cash flow, with more consistent year-over-year improvement.
BWAY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -4.5x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -5.2x | Net Cash |
| Q3 2025 | -6.6x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -10.0x | Net Cash |
| Q4 2024 | -11.9x | Net Cash |
| Q3 2024 | -8.6x | Net Cash |
BWAY has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
BWAY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.9 | Oversold |
| Stochastic | 5.3 | Oversold |
BWAY's weekly RSI is 30 (oversold) and its Stochastic is 5 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
BWAY PE vs Healthcare Sector
| Metric | BWAY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BWAY has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
BWAY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.6 | 12% below |
| 20 week MA | $13.6 | 25% below |
| 50 week MA | $13.2 | 22% below |
| 100 week MA | $9.61 | 6.7% above |
| 200 week MA | $6.08 | 69% above |
BWAY has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 69% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over BWAY on trend strength, trading above more of its moving averages.
BWAY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.85 | $3.09 | -36% |
| 2021 | $3.09 | $3.76 | +22% |
| 2022 | $3.76 | $1.08 | -71% |
| 2023 | $1.08 | $3.24 | +200% |
| 2024 | $3.24 | $4.57 | +41% |
| 2025 | $4.57 | $9.69 | +112% |
| 2026 YTD | $9.69 | $10.3 | +5.8% |
BWAY's yearly returns have swung widely, from +200% in 2023 to −71% in 2022. It's up 5.8% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over BWAY on returns for 2026, with the stronger performance.